Search Results - McLeroth, Patrick L

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    731. CERTAIN-1: A Phase 3 Study of Cefepime-Taniborbactam Efficacy and Safety in the Treatment of Complicated Urinary Tract Infections (cUTI), including Acute Pyelonephritis (AP)

    731. CERTAIN-1: A Phase 3 Study of Cefepime-Taniborbactam Efficacy and Safety in the Treatment of Complicated Urinary Tract Infections (cUTI), including Acute Pyelonephritis (AP) by McGovern, Paul C, Wagenlehner, Florian, Gasink, Leanne, Moeck, Greg, McLeroth, Patrick L, Beth, Mary, Dane, Aaron, Henkel, Tim

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection

    Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection by Lucasti, Christopher, Vasile, Liviu, Sandesc, Dorel, Venskutonis, Donatas, McLeroth, Patrick, Lala, Mallika, Rizk, Matthew L, Brown, Michelle L, Losada, Maria C, Pedley, Alison, Kartsonis, Nicholas A, Paschke, Amanda

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

    Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients wi... by Sims, Matthew, Mariyanovski, Valeri, McLeroth, Patrick, Akers, Wayne, Lee, Yu-Chieh, Brown, Michelle L, Du, Jiejun, Pedley, Alison, Kartsonis, Nicholas A, Paschke, Amanda

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1

    A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin... by Huang, David B, O'Riordan, William, Overcash, J Scott, Heller, Barry, Amin, Faisal, File, Thomas M, Wilcox, Mark H, Torres, Antoni, Dryden, Matthew, Holland, Thomas L, McLeroth, Patrick, Shukla, Rajesh, Corey, G Ralph

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)

    A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin... by Holland, Thomas L, O'Riordan, William, McManus, Alison, Shin, Elliot, Borghei, Ali, File, Jr, Thomas M, Wilcox, Mark H, Torres, Antoni, Dryden, Matthew, Lodise, Thomas, Oguri, Toyoko, Corey, G Ralph, McLeroth, Patrick, Shukla, Rajesh, Huang, David B

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: